跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,137 条关于
“G1/S”
全部
9,137
临床试验
3,008
药物
1,675
机构
237
资讯
4,217
2年前
Pharmacosmos Group Acquires G1 Therapeutics for $405 Million to Expand COSELA Access for Cancer Patients
去年
Dana-Farber Researchers Launch Phase 1 Trial of Novel Cyclin Inhibitor for Small Cell Lung Cancer
9个月前
4D Path's AI Platform Predicts Chemotherapy Response in Triple-Negative Breast Cancer Using Standard Biopsy Images
2年前
FDA Lifts Partial Clinical Hold on Zentalis' Azenosertib Studies
去年
Zentalis Pharmaceuticals Restructures to Advance Azenosertib in Gynecological Cancers
去年
Immune-Based AML Subgroups Reveal Prognostic and Therapeutic Implications
11个月前
Zentalis Pharmaceuticals Presents Four Azenosertib Studies at AACR-NCI-EORTC Conference
8个月前
Zentalis Advances Azenosertib Toward Potential Accelerated Approval with Key 2026 Milestones in Ovarian Cancer
去年
Novel CDK2 Inhibitor INX-315 Shows Promise in Overcoming Cancer Drug Resistance, Study Reveals
去年
Pharmacosmos Completes Strategic Acquisition of G1 Therapeutics in Multi-Million Dollar Deal
第 1 页,共 422 页
上一页
下一页